on Bb Biotech (isin : CH0038389992)
BB Biotech AG Reports Significant Profit for 2025
BB Biotech AG, a prominent investment company, has announced a significant profit for the fiscal year 2025. According to preliminary unaudited consolidated figures, the company achieved a profit of approximately CHF 578 million. This marks a substantial increase from the CHF 76 million profit reported in the previous year.
The company's performance in 2025 reflects the positive share price development of the companies within its portfolio. BB Biotech AG is recognized for its investments in innovative drug developers, primarily based in the US and Western Europe. The full annual report, with comprehensive portfolio data, is scheduled for release on February 20, 2026.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Bb Biotech news